{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:25:17Z","timestamp":1759883117313,"version":"build-2065373602"},"reference-count":57,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Untreated hyperprolactinemia and autoimmune thyroiditis (Hashimoto\u2019s disease) seem to increase cardiometabolic risk. The cardiometabolic effects of cabergoline were less significant in young women with concurrent euthyroid Hashimoto\u2019s illness. This study sought to investigate if the detrimental effects of this condition on cabergoline efficacy are also evident in postmenopausal women. Methods: The study comprised 50 postmenopausal women exhibiting increased prolactin levels, with half qualifying for euthyroid Hashimoto\u2019s illness. The subjects with thyroid autoimmunity were matched with those without thyroid disease according to age, body mass index, and prolactin levels. In addition to prolactin, we assessed thyroid-stimulating hormone (TSH), thyroid antibodies, and glucose homeostasis markers: fasting glucose, the homeostatic model assessment 1 of insulin resistance ratio (HOMA1-IR), and glycated hemoglobin (HbA1c). Furthermore, we assessed plasma lipids, plasma uric acid levels, high-sensitivity C-reactive protein (hsCRP), fibrinogen, homocysteine, and the urine albumin-to-creatinine ratio (UACR). The decadal cardiovascular risk was assessed with the Framingham Risk Score (FRS). Results: Before therapy, disparities existed among groups in HOMA1-IR, HDL cholesterol, antibody titers, uric acid, hsCRP, fibrinogen, homocysteine, UACR, and FRS. After six months of treatment, cabergoline successfully corrected prolactin levels (both total and monomeric) in women without thyroid disorders. This normalization correlated with decreases in HOMA1-IR, triglycerides, uric acid, hsCRP, fibrinogen, homocysteine, UACR, and FRS, as well as an elevation in HDL cholesterol. In women diagnosed with Hashimoto\u2019s disease, cabergoline\u2019s effects were limited to a reduction in prolactin levels, HOMA1-IR, and UACR, as well as an elevation in HDL cholesterol, with these alterations being less pronounced compared to women without thyroid illness. Conclusions: The cardiometabolic benefits of cabergoline were associated with the degree of prolactin concentration reduction. In women diagnosed with Hashimoto\u2019s disease, connections were noted between baseline levels and treatment-induced alterations in hsCRP. These data indicate that concurrent euthyroid autoimmune thyroiditis mitigates the cardiometabolic consequences of cabergoline.<\/jats:p>","DOI":"10.3390\/metabo15010009","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T14:35:42Z","timestamp":1735742142000},"page":"9","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Influence of Concurrent Autoimmune Thyroiditis on the Cardiometabolic Consequences of Cabergoline in Postmenopausal Women"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-2620","authenticated-orcid":false,"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-5612","authenticated-orcid":false,"given":"Marcin","family":"Basiak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Szkr\u00f3bka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-2906","authenticated-orcid":false,"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.maturitas.2021.06.014","article-title":"Hyperprolactinemia after menopause: Diagnosis and management","volume":"151","author":"Auriemma","year":"2021","journal-title":"Maturitas"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.5603\/EP.a2022.0075","article-title":"Hyperprolactinemia and insulin resistance","volume":"73","author":"Gierach","year":"2022","journal-title":"Endokrynol. Pol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Auriemma, R.S., De Alcubierre, D., Pirchio, R., Pivonello, R., and Colao, A. (2019). Glucose abnormalities associated to prolactin secreting pituitary adenomas. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00327"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11102-013-0495-z","article-title":"Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: A pilot study","volume":"17","author":"Jiang","year":"2014","journal-title":"Pituitary"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1490187","article-title":"Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic premenopausal women","volume":"149","author":"Yavuz","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4158\/EP13173.OR","article-title":"Preclinical atherosclerosis in patients with prolactinoma","volume":"20","author":"Arslan","year":"2014","journal-title":"Endocr. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2265.2009.03752.x","article-title":"Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma","volume":"73","author":"Erem","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.06840711","article-title":"Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD","volume":"7","author":"Carrero","year":"2012","journal-title":"Clin. Am. J. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jcu.23030","article-title":"Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question","volume":"49","author":"Yazici","year":"2021","journal-title":"J. Clin. Ultrasound"},{"key":"ref_10","first-page":"440","article-title":"Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma","volume":"16","author":"Tuna","year":"2016","journal-title":"Anatol. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.109.132100","article-title":"Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors","volume":"54","author":"Georgiopoulos","year":"2009","journal-title":"Hypertension"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/jhh.2017.15","article-title":"Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause","volume":"31","author":"Georgiopoulos","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/HJH.0b013e328339f254","article-title":"Plasma prolactin level and risk of incident hypertension in postmenopausal women","volume":"28","author":"Zhang","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-2006-955090","article-title":"Increased prolactin in acute coronary syndromes as putative co-activator of ADP-stimulated P-selectin expression","volume":"38","author":"Raaz","year":"2006","journal-title":"Horm. Metab. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1160\/TH05-09-0634","article-title":"Enhanced platelet activation by prolactin in patients with ischemic stroke","volume":"96","author":"Wallaschofski","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.jcp.0000088914.24613.51","article-title":"Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: Pilot study","volume":"23","author":"Wallaschofski","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ciccone, M.M., De Pergola, G., Porcelli, M.T., Scicchitano, P., Caldarola, P., and Iacoviello, M. (2010). Increased carotid IMT in overweight and obese women affected by Hashimoto\u2019s thyroiditis: An adiposity and autoimmune linkage?. BMC Cardiovasc. Disord., 10.","DOI":"10.1186\/1471-2261-10-22"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2006.02531.x","article-title":"Impairment of endothelium-dependent arterial dilation in Hashimoto\u2019s thyroiditis patients with euthyroidism","volume":"64","author":"Xiang","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/thy.2008.0326","article-title":"Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto\u2019s thyroiditis: The effect of menopausal status","volume":"19","author":"Stamatelopoulos","year":"2009","journal-title":"Thyroid"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/a-1178-5882","article-title":"The relationship between the impairment of endothelial function and thyroid antibodies in Hashimoto\u2019s thyroiditis patients with euthyroidism","volume":"52","author":"Hu","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Liu, J., Duan, Y., Fu, J., and Wang, G. (2018). Association between thyroid hormones, thyroid antibodies, and cardiometabolic factors in nonobese individuals with normal thyroid function. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00130"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1856137","DOI":"10.1155\/2018\/1856137","article-title":"Are thyroid autoimmune diseases are associated with cardiometabolic risks in a population with normal thyroid-stimulating hormone?","volume":"2018","author":"Chen","year":"2018","journal-title":"Mediators Inflamm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1210\/jc.2010-2986","article-title":"The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto\u2019s thyroiditis","volume":"96","author":"Krysiak","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000529242","article-title":"Cardiometabolic risk factors in atorvastatin-treated women with euthyroid autoimmune thyroiditis","volume":"108","author":"Krysiak","year":"2023","journal-title":"Pharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1089\/thy.2005.15.718","article-title":"Thyroid disease and increased cardiovascular risk","volume":"15","author":"Nyirenda","year":"2005","journal-title":"Thyroid"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-3-642-30726-3_17","article-title":"Thyroid disorders","volume":"214","author":"Gessl","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.vh.2017.07.001","article-title":"Thyroid autoimmunity: An interplay of factors","volume":"106","author":"Merrill","year":"2018","journal-title":"Vitam. Horm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: Epidemiology, pathogenesis, clinic and therapy","volume":"34","author":"Ragusa","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_29","first-page":"157","article-title":"Cardiovascular risk in patients with subclinical hypothyroidism","volume":"10","author":"Duntas","year":"2014","journal-title":"Eur. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jcph.2245","article-title":"Autoimmune thyroiditis attenuates cardiometabolic effects of cabergoline in young women with hyperprolactinemia","volume":"63","author":"Krysiak","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.mcna.2015.01.007","article-title":"Cardiovascular risk factors and disease in women","volume":"99","author":"Gill","year":"2015","journal-title":"Med. Clin. North Am."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107974","DOI":"10.1016\/j.maturitas.2024.107974","article-title":"Menopause transition and cardiovascular disease risk","volume":"185","author":"Uddenberg","year":"2024","journal-title":"Maturitas"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1515\/cclm-2018-0074","article-title":"Observational studies on macroprolactin in a routine clinical laboratory","volume":"56","author":"Barth","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0042-117718","article-title":"A neutral effect of metformin treatment on macroprolactin content in women with macroprolactinemia","volume":"125","author":"Krysiak","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Krysiak, R., Kowalcze, K., Madej, A., and Okopie\u0144, B. (2023). The effect of metformin on plasma prolactin levels in young women with autoimmune thyroiditis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12113769"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"Bizzarro","year":"2005","journal-title":"Pituitary"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Borba, V.V., Zandman-Goddard, G., and Shoenfeld, Y. (2018). Prolactin and autoimmunity. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00073"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","article-title":"Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies","volume":"36","author":"Kramer","year":"2005","journal-title":"Arch. Med. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/cen.12217","article-title":"Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma","volume":"79","author":"Sahin","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1357-2725(99)00032-1","article-title":"Fibrinogen","volume":"31","author":"Herrick","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","article-title":"Diabetic nephropathy and inflammation","volume":"5","year":"2014","journal-title":"World J. Diabetes"},{"key":"ref_43","first-page":"1179573520962230","article-title":"Hyperhomocysteinemia: Clinical Insights","volume":"12","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11926-010-0092-3","article-title":"Update on biology: Uric acid and the activation of immune and inflammatory cells","volume":"12","author":"Martinon","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Krysiak, R., Kowalcze, K., Szkr\u00f3bka, W., and Okopie\u0144, B. (2023). Sexual function and depressive symptoms in young women with euthyroid Hashimoto thyroiditis receiving vitamin D, selenomethionine and myo-inositol: A pilot study. Nutrients, 15.","DOI":"10.3390\/nu15122815"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Rizo-T\u00e9llez, S.A., Sekheri, M., and Filep, J.G. (2023). C-reactive protein: A target for therapy to reduce inflammation. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1237729"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Krysiak, R., Basiak, M., Machnik, G., and Okopie\u0144, B. (2023). Impaired gonadotropin-lowering effects of metformin in postmenopausal women with autoimmune thyroiditis: A pilot study. Pharmaceuticals, 16.","DOI":"10.3390\/ph16070922"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuroscience.2004.04.057","article-title":"Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat","volume":"127","author":"Abreu","year":"2004","journal-title":"Neuroscience"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Faulkner, J.L., and Belin de Chantem\u00e8le, E.J. (2019). Sex hormones, aging and cardiometabolic syndrome. Biol. Sex Differ., 10.","DOI":"10.1186\/s13293-019-0246-6"},{"key":"ref_50","first-page":"245","article-title":"Macroprolactinemia: A mini-review and update on clinical practice","volume":"4","author":"Koniares","year":"2023","journal-title":"F. S. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Olson, A.L. (2012). Regulation of GLUT4 and insulin-dependent glucose flux. ISRN Mol. Biol., 2012.","DOI":"10.5402\/2012\/856987"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101241","DOI":"10.1016\/j.molmet.2021.101241","article-title":"Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes","volume":"51","author":"Tavares","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression","volume":"148","author":"Jager","year":"2007","journal-title":"Endocrinology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1006865715292","article-title":"TNF-alpha and insulin resistance: Summary and future prospects","volume":"182","author":"Peraldi","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00384-015-2490-5","article-title":"Induction of GLUT4 by inhibiting IFN-\u03b3: A winning move to halt type 2 diabetes?","volume":"31","author":"Mormile","year":"2016","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1098-3597(05)80065-1","article-title":"The metabolic basis of atherogenic dyslipidemia","volume":"7","author":"Vinik","year":"2005","journal-title":"Clin. Cornerstone"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/070674370104600111","article-title":"Regression toward the mean: Its etiology, diagnosis, and treatment","volume":"46","author":"Streiner","year":"2001","journal-title":"Can. J. Psychiatry"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/1\/9\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:23:06Z","timestamp":1759850586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/1\/9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["metabo15010009"],"URL":"https:\/\/doi.org\/10.3390\/metabo15010009","relation":{},"ISSN":["2218-1989"],"issn-type":[{"type":"electronic","value":"2218-1989"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}